William Blair Forecasts InnovAge’s Q3 Earnings (NASDAQ:INNV)

InnovAge Holding Corp. (NASDAQ:INNV) – Investment analysts at William Blair dropped their Q3 2025 earnings per share (EPS) estimates for shares of InnovAge in a report issued on Tuesday, November 5th. William Blair analyst J. Haase now expects that the company will earn ($0.02) per share for the quarter, down from their previous forecast of ($0.01). The consensus estimate for InnovAge’s current full-year earnings is ($0.02) per share. William Blair also issued estimates for InnovAge’s FY2025 earnings at ($0.06) EPS.

InnovAge (NASDAQ:INNV) last released its quarterly earnings results on Tuesday, November 5th. The company reported ($0.04) earnings per share for the quarter, meeting the consensus estimate of ($0.04). The firm had revenue of $205.14 million for the quarter, compared to analysts’ expectations of $203.35 million. InnovAge had a negative return on equity of 5.68% and a negative net margin of 2.03%. During the same period in the prior year, the firm earned ($0.08) EPS.

Separately, KeyCorp initiated coverage on InnovAge in a report on Friday, October 11th. They set a “sector weight” rating on the stock.

InnovAge Price Performance

NASDAQ INNV opened at $6.00 on Friday. The business’s fifty day moving average price is $5.91 and its 200-day moving average price is $5.40. The stock has a market capitalization of $812.76 million, a price-to-earnings ratio of -50.00 and a beta of 0.39. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.21 and a quick ratio of 1.25. InnovAge has a 1-year low of $3.52 and a 1-year high of $6.69.

Institutional Investors Weigh In On InnovAge

Institutional investors have recently bought and sold shares of the business. Rhumbline Advisers increased its stake in InnovAge by 7.0% in the 2nd quarter. Rhumbline Advisers now owns 27,503 shares of the company’s stock worth $136,000 after buying an additional 1,793 shares in the last quarter. Bank of New York Mellon Corp increased its stake in InnovAge by 27.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 58,322 shares of the company’s stock worth $289,000 after buying an additional 12,448 shares in the last quarter. Accordant Advisory Group Inc purchased a new stake in InnovAge in the 2nd quarter worth $496,000. Renaissance Technologies LLC increased its stake in InnovAge by 3.1% in the 2nd quarter. Renaissance Technologies LLC now owns 136,400 shares of the company’s stock worth $677,000 after buying an additional 4,100 shares in the last quarter. Finally, Kent Lake Capital LLC increased its stake in InnovAge by 3.7% in the 1st quarter. Kent Lake Capital LLC now owns 1,750,000 shares of the company’s stock worth $7,770,000 after buying an additional 62,141 shares in the last quarter. Hedge funds and other institutional investors own 12.26% of the company’s stock.

Insider Transactions at InnovAge

In other news, insider Nicole Damato sold 4,372 shares of the company’s stock in a transaction on Monday, September 16th. The stock was sold at an average price of $5.95, for a total value of $26,013.40. Following the completion of the sale, the insider now directly owns 240,795 shares in the company, valued at $1,432,730.25. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.41% of the stock is currently owned by company insiders.

About InnovAge

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.